cbdMD, Inc.YCBDNYSE
Loading
YCBD Revenue Growth (YoY Quarterly)•-1.89%
Stock Alarm Pro
Growth Metrics
Latest: Q4 2025vs Q3 2025
Revenue GrowthGross Profit GrowthEBITDA GrowthOperating Income GrowthNet Income GrowthEPS GrowthEPS Diluted GrowthWeighted Average Shares GrowthWeighted Average Shares Diluted GrowthDividends per Share Growth
-1.89%
-5.5pp
-11.18%
-17.0pp
-48.45%
-48.5pp
+0.00%
+0.0pp
-1975.66%
-1975.7pp
+0.00%
+0.0pp
+0.00%
+0.0pp
+97.80%
-9.0pp
+97.80%
-9.0pp
+0.00%
+0.0pp
| Metric | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 |
|---|---|---|---|---|---|
| Revenue Growth | -4.87% | +8.52% | -10.96% | +3.61% | -1.89% |
| Gross Profit Growth | -5.23% | +16.74% | -18.13% | +5.78% | -11.18% |
| EBITDA Growth | +0.00% | +0.00% | -324.11% | +0.00% | -48.45% |
| Operating Income Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Net Income Growth | +0.00% | +0.00% | -294.74% | +0.00% | -1975.66% |
| EPS Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EPS Diluted Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Weighted Average Shares Growth | +53.74% | +74.52% | +60.96% | +106.77% | +97.80% |
| Weighted Average Shares Diluted Growth | +53.74% | +162.88% | +60.96% | +106.77% | +97.80% |
| Dividends per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Cash Flow Growth | +0.00% | +0.00% | -343.01% | -345.96% | +0.00% |
| Free Cash Flow Growth | +0.00% | +0.00% | -343.52% | -377.14% | +0.00% |
| Receivables Growth | +15.48% | +21.18% | +5.60% | +5.79% | -12.19% |
| Inventory Growth | -43.46% | -22.86% | -13.24% | +15.51% | +48.60% |
| Asset Growth | -23.53% | -24.83% | -28.52% | -1.53% | +2.07% |
| Book Value per Share Growth | -83.53% | -87.64% | +25.37% | +77.99% | +155.62% |
| Debt Growth | -51.75% | -80.10% | -76.57% | -38.72% | +36385.62% |
| R&D Expense Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| SG&A Expenses Growth | -25.35% | -16.48% | -1.21% | +21.86% | -4.60% |
1 / 4